Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology | Gastroenterology | Family Medicine

Nephropathy Clinical Trials

A listing of Nephropathy medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 Last 

Alabama

Site Reference ID/Investigator# 105317
Birmingham Alabama 35211

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Arizona

Site Reference ID/Investigator# 106300
Peoria Arizona 85381

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107196
Phoenix Arizona 85032

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 118549
Prescott Arizona 86301

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 110376
Tucson Arizona 85712

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Arkansas

Site Reference ID/Investigator# 107678
Little Rock Arkansas 72223

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

California

Site Reference ID/Investigator# 99948
Alhambra California 91801

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96605
Azusa California 91702

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 101579
Azusa California 91702

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 114816
Bakersfield California 93309

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99975
Chula Vista California 91911

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

View More »

Site Reference ID/Investigator# 96591
Chula Vista California 91910

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105498
Corona California 92880

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105566
Downey California 90241

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 101476
Fullerton California 92835

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96597
La Mesa California 91942

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99397
Los Angeles California 90036

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96596
Los Angeles California 90022

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 104915
Los Angeles California 90059

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96704
Mission Hills California 91345

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 102095
North Hollywood California 91606

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105199
Norwalk California 90650

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107200
Orange California 92868

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96702
Palm Springs California 92262

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 110415
Paramount California 90723

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105576
Porterville California 93257

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 107455
Riverside California 92505

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 104900
Sacramento California 95825

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105316
San Diego California 92123

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96640
Santa Barbara California 93110

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Connecticut

Site Reference ID/Investigator# 104911
Stamford Connecticut 06902

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Delaware

Site Reference ID/Investigator# 106297
Newark Delaware 19713

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

District of Columbia

Site Reference ID/Investigator# 96707
Washington District of Columbia 20037

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Florida

Site Reference ID/Investigator# 117452
Aventura Florida 33180

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105438
Coral Springs Florida 33071

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105315
Fort Myers Florida 33912

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 116195
Hialeah Florida 33012

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 99897
Kissimmee Florida 34741

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

View More »

Site Reference ID/Investigator# 118315
Miami Florida 33122

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 111220
Miami Florida 33015

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 111221
Orlando Florida 32806

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 111223
Pembroke Pines Florida 33026

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96623
Pembroke Pines Florida 33028

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105436
Port Charlotte Florida 33983

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105196
St. Cloud Florida 34741

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 118760
St. Petersburg Florida 33713

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 106296
Tampa Florida 33606

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 96606
West Palm Beach Florida 33401

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Georgia

Site Reference ID/Investigator# 107999
Decatur Georgia 30030

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Site Reference ID/Investigator# 105177
Dunwoody Georgia 30338

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

First 1 2 3 4 5 Last